Critically, survival probability in COAD patients expressing elevated M2 and TAM related genes, viz, TGFβ1, CD68, FABP4, and VEGFA demonstrated lesser prospect of survival (Figure S10B in Supplementary Material) (27–30). This evidence concerns the gene CD68 and colon adenocarcinoma.